OAS Antibodies

Santa Cruz Biotechnology features a diverse variety of OAS Antibodies for investigating 2',5'-oligoadenylate synthetases (OAS) in cellular processes. OAS Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). 2',5'-oligoadenylate synthetases (OAS) are key components in the innate immune response, particularly in detecting viral infections. The synthesis of 2',5'-oligoadenylates activates RNase L, which leads to viral RNA degradation and inhibits viral replication. Understanding 2',5'-oligoadenylate synthetases (OAS) function is vital for developing therapeutic strategies against viral diseases and advancing immune regulation knowledge. Researchers worldwide use OAS monoclonal antibodies to explore immune response mechanisms and viral defense pathways. Current investigations focus on how 2',5'-oligoadenylate synthetases (OAS) respond to different viral threats and regulate immune system activation. Ongoing studies examine the relationship between OAS activity and various autoimmune conditions. Santa Cruz Biotechnology monoclonal antibodies support cutting-edge research in virology and immunology, helping scientists uncover new insights into immune system function and viral defense mechanisms.